Mind Medicine (MindMed) (OTCMKTS:MMEDF) Shares Up 12.9% – Still a Buy?

Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF)’s stock price shot up 12.9% on Friday . The company traded as high as $9.15 and last traded at $8.49. 4,633,673 shares traded hands during mid-day trading, an increase of 37% from the average session volume of 3,376,665 shares. The stock had previously closed at $7.52.

Mind Medicine (MindMed) Trading Up 12.9 %

The company’s fifty day simple moving average is $6.00 and its 200-day simple moving average is $7.24.

Mind Medicine (MindMed) Company Profile

Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.